BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

22 hedge funds and large institutions have $2.68M invested in Bellerophon Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.1K
2
+$2.23K
3
+$819

Top Sellers

1
-$86.6K
2
-$45.2K
3
-$35K
4
Millennium Management
Millennium Management
New York
-$30.7K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$23.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$852K
2
$472K
3
$437K
4
$285K
5
$197K
6
$137K
7
$88K
8
$66K
9
$50K
10
$47K
11
$26K
12
$6K
13
$5K
14
$4K
15
$3K
16
$2K
17
$1K
18
$1K
19
$1K
20
–